Fludarabine for chronic lymphocytic leukemia.
Marchetti
M
M
Barosi
G
G
Liberato
L N
LN
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D002699:Chlorambucil / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D018572:Disease-Free Survival; D016527:Drug Costs; D006801:Humans; D007558:Italy; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000191:economics; D026712:Value of Life; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000191:economics* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002699:Chlorambucil; D014740:Vidarabine; C024352:fludarabine